表紙:直接販売(DTC)遺伝子検査の世界市場(2021年~2025年)
市場調査レポート
商品コード
1018317

直接販売(DTC)遺伝子検査の世界市場(2021年~2025年)

Global Direct-To-Consumer Genetic Testing Market 2021-2025

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
直接販売(DTC)遺伝子検査の世界市場(2021年~2025年)
出版日: 2021年05月31日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

直接販売(DTC)遺伝子検査の市場規模は、2021年から2025年の間に16%を超えるCAGRで推移し、13億9,000万米ドルの成長が見込まれています。

直接販売(DTC)遺伝子検査市場に関する当レポートは、全体的な分析、市場規模と予測、動向、成長要因、課題、および約25のベンダーをカバーするベンダー分析を提供します。

同市場は、早期の病気診断における直接販売遺伝子検査の採用増加、可処分所得の増加、および直接販売遺伝子検査キットの規制当局おる承認増加によって促進されています。さらに、早期の病気診断における直接販売遺伝子検査の採用増加は、市場の成長も後押しすると予想されます。

当レポートでは、直接販売(DTC)遺伝子検査市場を調査しており、市場の概要、市場規模、市場の見通し、顧客情勢、流通チャネル別・サービス別・地域別の分析、さらにベンダー情勢とベンダー分析などを提供しています。

目次

  • エグゼクティブサマリー
    • 市場概要
  • 市場情勢
    • 市場のエコシステム
    • バリューチェーン分析
  • 市場規模
    • 市場の定義
    • 市場セグメント分析
    • 市場規模:2020年
    • 市場の見通し:2020年から2025年の予測
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争の脅威
    • 市況
  • 流通チャネル別市場セグメンテーション
    • マーケット・セグメント
    • 流通チャネル別比較
    • 直接販売:市場規模と予測(2020年~2025年)
    • 小売:市場規模と予測(2020年~2025年)
    • 流通チャネル別の市場機会
  • サービス別市場セグメンテーション
    • マーケット・セグメント
    • サービス別比較
    • 診断スクリーニング:市場規模と予測(2020年~2025年)
    • 関係テスト:市場規模と予測(2020年~2025年)
    • サービス別の市場機会
  • 顧客情勢
  • 地域別情勢
    • 地域別セグメンテーション
    • 地域別比較
    • 北米:市場規模と予測(2020年~2025年)
    • 欧州:市場規模と予測(2020年~2025年)
    • アジア:市場規模と予測(2020年~2025年)
    • その他の地域:市場規模と予測(2020年~2025年)
    • 主要国
    • 地域別情勢市場機会
    • 市場成長促進要因
    • 市場の課題
    • 市場動向
  • ベンダー情勢
    • 概要
    • 創造的破壊の状況
  • ベンダー分析
    • 対象ベンダー
    • ベンダーの市場ポジショニング
    • 23andMe Inc.
    • Alpha Biolaboratories Ltd.
    • セントリリオンテクノロジーホールディングス株式企業
    • Color Genomics Inc.
    • Dante Labs Inc.
    • DNA診断センター株式企業
    • Full Genomes Corp.
    • ラボラトリーコーポレーションオブアメリカホールディングス
    • Myriad Genetics Inc.
    • Quest Diagnostics Inc.
  • 付録
    • 調査範囲
    • US$の為替レート
    • 調査手法
    • 略語のリスト
目次
Product Code: IRTNTR45124

Technavio has been monitoring the direct-to-consumer genetic testing market and it is poised to grow by $ 1.39 bn during 2021-2025, progressing at a CAGR of over 16% during the forecast period. Our report on direct-to-consumer genetic testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing adoption of direct-to-consumer genetic testing in early disease diagnosis, rising disposable income, and increasing regulatory approvals of direct-to-consumer genetic testing kits. In addition, growing adoption of direct-to-consumer genetic testing in early disease diagnosis is anticipated to boost the growth of the market as well.

The direct-to-consumer genetic testing market analysis includes distribution channel segment, service segment, and geographic landscape.

Technavio's direct-to-consumer genetic testing market is segmented as below:

By Distribution Channel

  • Direct sales
  • Retail sales

By Service

  • Diagnostic screening
  • Prenatal, newborn screening, and pre-implantation diagnosis
  • Relationship testing

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the advances in next-generation genetic sequencing as one of the prime reasons driving the direct-to-consumer genetic testing market growth during the next few years. Also, reduction in the cost of services and growing adoption of online service platforms will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on direct-to-consumer genetic testing market covers the following areas:

  • Direct-to-consumer genetic testing market sizing
  • Direct-to-consumer genetic testing market forecast
  • Direct-to-consumer genetic testing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading direct-to-consumer genetic testing market vendors that include 23andMe Inc., Alpha Biolaboratories Ltd., Centrillion Technology Holdings Ltd., Color Genomics Inc., Dante Labs Inc., DNA Diagnostic Center Inc., Full Genomes Corp., Laboratory Corp. of America Holdings, Myriad Genetics Inc., and Quest Diagnostics Inc. Also, the direct-to-consumer genetic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Distribution channel
    • Market segments
    • Comparison by Distribution channel
    • Direct sales - Market size and forecast 2020-2025
    • Retail sales - Market size and forecast 2020-2025
    • Market opportunity by Distribution channel
  • Market Segmentation by Service
    • Market segments
    • Comparison by Service
    • Diagnostic screening - Market size and forecast 2020-2025
    • Relationship testing - Market size and forecast 2020-2025
    • Market opportunity by Service
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • 23andMe Inc.
    • Alpha Biolaboratories Ltd.
    • Centrillion Technology Holdings Ltd.
    • Color Genomics Inc.
    • Dante Labs Inc.
    • DNA Diagnostic Center Inc.
    • Full Genomes Corp.
    • Laboratory Corp. of America Holdings
    • Myriad Genetics Inc.
    • Quest Diagnostics Inc.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Key Finding 9
  • 9: Parent market
  • 10: Market characteristics
  • 11: Offerings of vendors included in the market definition
  • 12: Market segments
  • 13: Global - Market size and forecast 2020 - 2025 ($ million)
  • 14: Global market: Year-over-year growth 2020 - 2025 (%)
  • 15: Five forces analysis 2020 & 2025
  • 16: Bargaining power of buyers
  • 17: Bargaining power of suppliers
  • 18: Threat of new entrants
  • 19: Threat of substitutes
  • 20: Threat of rivalry
  • 21: Market condition - Five forces 2020
  • 22: Distribution channel - Market share 2020-2025 (%)
  • 23: Comparison by Distribution channel
  • 24: Direct sales - Market size and forecast 2020-2025 ($ million)
  • 25: Direct sales - Year-over-year growth 2020-2025 (%)
  • 26: Retail sales - Market size and forecast 2020-2025 ($ million)
  • 27: Retail sales - Year-over-year growth 2020-2025 (%)
  • 28: Market opportunity by Distribution channel
  • 29: Service - Market share 2020-2025 (%)
  • 30: Comparison by Service
  • 31: Diagnostic screening - Market size and forecast 2020-2025 ($ million)
  • 32: Diagnostic screening - Year-over-year growth 2020-2025 (%)
  • 33: Prenatal, newborn screening, and pre-implantation diagnosis - Market size and forecast 2020-2025 ($ million)
  • 34: Prenatal, newborn screening, and pre-implantation diagnosis - Year-over-year growth 2020-2025 (%)
  • 35: Relationship testing - Market size and forecast 2020-2025 ($ million)
  • 36: Relationship testing - Year-over-year growth 2020-2025 (%)
  • 37: Market opportunity by Service
  • 38: Customer landscape
  • 39: Market share By Geographical Landscape 2020-2025 (%)
  • 40: Geographic comparison
  • 41: North America - Market size and forecast 2020-2025 ($ million)
  • 42: North America - Year-over-year growth 2020-2025 (%)
  • 43: Europe - Market size and forecast 2020-2025 ($ million)
  • 44: Europe - Year-over-year growth 2020-2025 (%)
  • 45: Asia - Market size and forecast 2020-2025 ($ million)
  • 46: Asia - Year-over-year growth 2020-2025 (%)
  • 47: ROW - Market size and forecast 2020-2025 ($ million)
  • 48: ROW - Year-over-year growth 2020-2025 (%)
  • 49: Key leading countries
  • 50: Market opportunity By Geographical Landscape ($ million)
  • 51: Impact of drivers and challenges
  • 52: Vendor landscape
  • 53: Landscape disruption
  • 54: Industry risks
  • 55: Vendors covered
  • 56: Market positioning of vendors
  • 57: 23andMe Inc. - Overview
  • 58: 23andMe Inc. - Product and service
  • 59: 23andMe Inc. - Key offerings
  • 60: 23andMe Inc. - Key customers
  • 61: 23andMe Inc. - Segment focus
  • 62: Alpha Biolaboratories Ltd. - Overview
  • 63: Alpha Biolaboratories Ltd. - Product and service
  • 64: Alpha Biolaboratories Ltd. - Key offerings
  • 65: Alpha Biolaboratories Ltd. - Key customers
  • 66: Alpha Biolaboratories Ltd. - Segment focus
  • 67: Centrillion Technology Holdings Ltd. - Overview
  • 68: Centrillion Technology Holdings Ltd. - Product and service
  • 69: Centrillion Technology Holdings Ltd. - Key offerings
  • 70: Centrillion Technology Holdings Ltd. - Key customers
  • 71: Centrillion Technology Holdings Ltd. - Segment focus
  • 72: Color Genomics Inc. - Overview
  • 73: Color Genomics Inc. - Product and service
  • 74: Color Genomics Inc. - Key offerings
  • 75: Color Genomics Inc. - Key customers
  • 76: Color Genomics Inc. - Segment focus
  • 77: Dante Labs Inc. - Overview
  • 78: Dante Labs Inc. - Product and service
  • 79: Dante Labs Inc. - Key offerings
  • 80: Dante Labs Inc. - Key customers
  • 81: Dante Labs Inc. - Segment focus
  • 82: DNA Diagnostic Center Inc. - Overview
  • 83: DNA Diagnostic Center Inc. - Product and service
  • 84: DNA Diagnostic Center Inc. - Key offerings
  • 85: DNA Diagnostic Center Inc. - Key customers
  • 86: DNA Diagnostic Center Inc. - Segment focus
  • 87: Full Genomes Corp. - Overview
  • 88: Full Genomes Corp. - Product and service
  • 89: Full Genomes Corp. - Key offerings
  • 90: Full Genomes Corp. - Key customers
  • 91: Full Genomes Corp. - Segment focus
  • 92: Laboratory Corp. of America Holdings - Overview
  • 93: Laboratory Corp. of America Holdings - Business segments
  • 94: Laboratory Corp. of America Holdings - Key offerings
  • 95: Laboratory Corp. of America Holdings - Key customers
  • 96: Laboratory Corp. of America Holdings - Segment focus
  • 97: Myriad Genetics Inc. - Overview
  • 98: Myriad Genetics Inc. - Business segments
  • 99: Myriad Genetics Inc. - Key offerings
  • 100: Myriad Genetics Inc. - Key customers
  • 101: Myriad Genetics Inc. - Segment focus
  • 102: Quest Diagnostics Inc. - Overview
  • 103: Quest Diagnostics Inc. - Business segments
  • 104: Quest Diagnostics Inc. - Key offerings
  • 105: Quest Diagnostics Inc. - Key customers
  • 106: Quest Diagnostics Inc. - Segment focus
  • 107: Currency conversion rates for US$
  • 108: Research Methodology
  • 109: Validation techniques employed for market sizing
  • 110: Information sources
  • 111: List of abbreviations